Radius Health, Inc.
RDUS
RDUS was delisted on the 12th of August, 2022.
0 hedge funds and large institutions have $0 invested in Radius Health, Inc. in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1.74M → $0 (-$1.74M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSC
Lesa Sroufe & Co
Seattle,
Washington
|
-$1.74M |
RDUS Hedge Fund Activity: Q4 2023 in Review
0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q4 2023, worth a combined $0 — down 100% from $1.74M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RDUS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Lesa Sroufe & Co, exiting entirely with an estimated $1.74M sold.
- 0 institutional investors held Radius Health, Inc. (RDUS) as of Q4 2023, down from 1 in Q3 2023.
- Funds reported $0 of Radius Health, Inc. stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Radius Health, Inc. positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest Radius Health, Inc. seller in Q4 2023 was Lesa Sroufe & Co, an estimated $1.74M sold.
Based on aggregated 13F filings for Q4 2023.